30.09.2016 – The 8th International Biotechnology Meeting, hosted at the BEC Barakaldo (Bilbao), coincided with European Biotech Week
Investors from 11 countries study 30 Spanish biotechnology projects
- 46 investors have attended the eigth edition of Biospain, including Edmond de Rothschild Investment Partners, Forbion, Johnson & Johnson Innovation, Novartis Venture Fund, Ysios Capital Partners, Caixa Capital Risc and Cross Road Biotech
- Biospain 2016 further consolidates its position as the fifth biggest event for business meetings, with 2,970 one-to-one meetings taking place
- The event was attended by 1,750 individuals and 701 entities from 29 countries, meaning there was an international presence of 28%
- 233 exhibitors came together for the event, with more exhibition space than at the previous edition
- 84.81% of survey respondents claimed to have identified real business opportunities
Read the full press release about BIOSPAIN 2016 here: ndp_conclusiones_biospain_2016_english
Recent Posts